Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease

scientific article published on 9 July 2008

Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/KI.2008.301
P698PubMed publication ID18615000
P5875ResearchGate publication ID5237774

P50authorWillem WeimarQ64124006
P2093author name stringMartin Huisman
Michiel G H Betjes
Nicolle H R Litjens
P2860cites workDirect access to CD4+ T cells specific for defined antigens according to CD154 expression.Q52936537
Perturbation of the T-Cell Repertoire in Patients With Unstable AnginaQ58230319
Healthy Aging and Latent Infection with CMV Lead to Distinct Changes in CD8+ and CD4+ T-Cell Subsets in the ElderlyQ58444239
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulationQ79213173
Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic diseaseQ80539356
Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjectsQ81039773
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalizationQ28283679
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaqueQ36227892
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturationQ36228210
Cardiovascular risk factors in chronic kidney diseaseQ36258100
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjectsQ36402863
Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of healthy elderly individualsQ38549412
Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factorsQ40430980
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromesQ42628689
Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescenceQ44551905
Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.Q44987477
IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells.Q45450773
Can we talk about CD4+CD28- lymphocytes as a risk factor for ischemic stroke?Q48177039
Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV.Q49174404
Hepatitis B vaccine-specific CD4(+) T cells can be detected and characterised at the single cell level: limited usefulness of dendritic cells as signal enhancers.Q51969019
Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion.Q51986471
Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes.Q51987587
Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.Q51995865
Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.Q51999308
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)760-767
P577publication date2008-07-09
P1433published inKidney InternationalQ6404823
P1476titleExpansion of cytolytic CD4+CD28- T cells in end-stage renal disease
P478volume74

Reverse relations

cites work (P2860)
Q59130614A comprehensive characterization of aggravated aging-related changes in T lymphocytes and monocytes in end-stage renal disease: the iESRD study
Q47397747An Early Immediate Early Protein IE-1-Specific T-Cell Polyfunctionality Is Associated With a Better Control of Cytomegalovirus Reactivation in Kidney Transplantation
Q55517769Anti-cytomegalovirus IgG antibody titer is positively associated with advanced T cell differentiation and coronary artery disease in end-stage renal disease.
Q36153925CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies
Q42393633CD4+ CD28-Negative Cells: Armed and Dangerous
Q50246473CD4+ CD28null T cells are not alloreactive unless stimulated by interleukin-15.
Q42726164CD4+ T cells, human cytomegalovirus and end-stage renal disease
Q37477756CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD
Q49985968CX3CL1/CX3CR1 axis, as The Therapeutic Potential In Renal Diseases: Friend Or Foe?
Q38268945Chronic kidney disease and premature ageing of the adaptive immune response.
Q43711233Circulating CD4(+)CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation.
Q50982075Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.
Q38568848Clinical consequences of circulating CD28-negative T cells for solid organ transplantation.
Q42275510Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment
Q40278985Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction
Q57371365Cytotoxic CD4 + CD28 null T Lymphocytes, Systemic Inflammation and Atherosclerotic Risk in Patients with Chronic Kidney Disease
Q39283173Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges
Q41972099Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets.
Q56526295ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications
Q43945551Encapsulating peritoneal sclerosis is associated with T-cell activation.
Q50880664Factors associated with the elevated percentage of CD4CD69 T cells in maintained hemodialysis patients.
Q37379921Heat shock proteins 60 and 70 specific proinflammatory and cytotoxic response of CD4+CD28null cells in chronic kidney disease
Q89547647High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation
Q42225364Human cytomegalovirus inhibits erythropoietin production.
Q52586069Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease.
Q36156499IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients
Q38090908Immune cell dysfunction and inflammation in end-stage renal disease
Q89719484Immunological Effects of a Single Hemodialysis Treatment
Q93065024Immunology of the ageing kidney
Q38787359Increased Pretransplant Frequency of CD28+ CD4+ TEM Predicts Belatacept-Resistant Rejection in Human Renal Transplant Recipients.
Q33780032Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).
Q64080824Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach
Q53674067Killer cell immunoglobulin receptor profile on CD4(+)  CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients.
Q34427302Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation.
Q39557444Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients
Q35948016Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation
Q40351573Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation.
Q37893442Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease
Q40736051Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections.
Q44954889Premature aging of circulating T cells in patients with end-stage renal disease.
Q98612947Presepsin Level Correlates with the Development of Moderate Coronary Artery Calcifications in Hemodialysis Patients: A Preliminary Cross-Section Design Study
Q41089597Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.
Q41684129Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
Q35694046Resistance of dialyzed patients to erythropoietin
Q64926518Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients.
Q42907197Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study
Q89688886T Lymphocyte Subsets Associated with Prevalent Diabetes in Veterans with and without HIV
Q38265548T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance.
Q92425260The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality
Q39031609The effect of chronic kidney disease on T cell alloimmunity
Q37541433Unusual CD4+CD28- T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders
Q40777703Uremia-Associated Premature Aging of T Cells Does Not Predict Infectious Complications After Renal Transplantation
Q50789254Uremia-associated immunological aging is stably imprinted in the T-cell system and not reversed by kidney transplantation.
Q57371300Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease
Q41091871pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients.

Search more.